参考文献/References:
1 Hoefnagel CA. Radionuclide therapy revisited[J]. Eur J Nucl Med,1991, 18(6):408-431.
2 de Kraker J, Hoefnagel CA, Caron H, et al. First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma[J]. Eur J Cancer, 1995, 31(4):600-602.
3 Mastrangelo R, Tornesello A, Losorella A, et al. Optimal use of the 131I-MIBG and cisplatin combination in advanced neuroblastoma[J].J Neuro Oncol, 1997, 31(1):153-158.
4 Feldman JM, Frankel M, Coleman RE. Platelet uptake thepheochromocytoma-scanning agent 131I-MIBG[J]. Metabolism, 1984, 33(5):397-399.
5 Meller S. Targeted radiotherapy for neuroblastoma[J]. Arch Dis Child,1997, 77(5):389-391.
6 Yanik GA, Levine JE, Matthay KK, et al. Pilot study of 131I-MIBG in combination with myelozblative chemotherapy and autologeus stem-cell support for treatment of neuroblastoma[J]. J Clin Oncol,2002, 20(8):2142-2149.
7 Mastrangelo S, Tornesello A, Diociaiuti L, et al. Treatment of advanced neuroblastoma:feasibility and therapeutic potential of a novel approach combining 131I-MIBG and multiple drug chemotheraoy[J]. BrJ Cancer, 2001, 84(4):460-464.
8 Klingebiel T, Bader P, Bares R, et al. Treatment of neuroblastoma stage 4 with 131I-MIBG, high dose chemotherapy and immuno therapy.A pilot study[J]. EurJ Cancer, 1998, 34(9):1398-1402.
9 Klingebiel T, Berthold F, Treuner J, et al. MIBG in the treatment of 47 patients with neuroblastoma:results of the German Neuroblastoma Trial[J]. Med Pediatr Oncol, 1991, 19(2):84-88.
10 Lashford LS, Lewis IJ, Fielding SL, et al. Phase I/Ⅱ study of iodine 131I-MIBG in Chemoresistant neuroblastoma:a United Kingdom Children’s Cancer Study Group investigation[J]. J Clin Oncol, 1992,10(12):1889-1896.
11 Brodeur GM, Pritchard J, Berthold F, et al. Revision of the international criteria for neuroblastoma diagnosis, staging and response to trestment[J]. J Clin Onco1,1993, 11(8):1466-1477.
12 Montalde PG, Raffaghello L, Guarnaccia F, et al. Increase of MIBG uptake and intracellular half-life during differentiation of human neuroblastoma cells[J]. Int J Cancer, 1996, 67(1):95-100.
13 Armour A, Cunningham SH, Gaze MN, et al. The effect of cisplatin pretreatment on the accumulation of MIBG by neuroblastoma cells in vitro[J]. Br J Cancer, 1997, 75(4):470-476.
14 Klingebiel T, Handgretinger R, Herter M, et al. Peripheral stem cell transplantation in neuroblastoma stage 4 with the use of 131I-MIBG.Prog[J]. Clin Biol Res, 1994, 385:309-317.
15 Voute PA, van de Kleij AJ, de kraker J, et al. Clinical experience with radiation euhancement by hyperbaric oxygen in children with recurrent neuroblastoma stage Ⅳ[J]. Eur J Cancer, 1995, 31A(4):596-600.
相似文献/References:
[1]刘阳,王会祥,周涛.神经母细胞瘤股骨远端干骺端骨转移全身骨显像分析[J].国际放射医学核医学杂志,2012,36(1):27.[doi:10.3760/cma.j.issn.1673-4114.2012.01.007]
LIU Yang,WANG Hui-xiang,ZHOU Tao.Application of semiquantitative analysis of whole body bone imaging on distal femoral metaphysis osseous metastasis of neuroblastoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(2):27.[doi:10.3760/cma.j.issn.1673-4114.2012.01.007]
[2]叶大铸,马寄晓.奥曲肽及其类似物用于肿瘤诊断的进展[J].国际放射医学核医学杂志,2003,27(3):97.
YE Da-zhu,MA Ji-xiao.Advances in tumor diagnosis with labeled somatostatin analogues[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(2):97.
[3]袁志斌.PET显像在内分泌肿瘤中的应用[J].国际放射医学核医学杂志,2003,27(5):208.
YUAN Zhi-bin.The application of PET in endocrine tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(2):208.
[4]邵虹.神经母细胞瘤的影像学诊断[J].国际放射医学核医学杂志,2002,26(4):148.
SHAO Hong.The imaging diagnosis of neuroblastoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(2):148.
[5]罗全勇.MIBG及其衍生物的研究进展[J].国际放射医学核医学杂志,2002,26(5):216.
LUO Quan-yong.The recent research progress of MIBG and its derivatives[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(2):216.
[6]傅宏亮,李佳宁,吴靖川.131I-MIBG治疗神经母细胞瘤的机制、原理和现状[J].国际放射医学核医学杂志,1999,23(6):247.